<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="Research Article" dtd-version="1.0"><front><journal-meta><journal-id journal-id-type="pmc">iajabms</journal-id><journal-id journal-id-type="pubmed">IAJABMS</journal-id><journal-id journal-id-type="publisher">IAJABMS</journal-id><issn>2709-3298</issn></journal-meta><article-meta><article-id pub-id-type="doi">https://doi.org/10.47310/iajabms.2025.v06i01.017</article-id><title-group><article-title>Molecular Genetics and Predictive Analytics in Ovarian Cancer Risk Stratification</article-title></title-group><contrib-group><contrib contrib-type="author"><name><given-names>Hasanain</given-names><surname>Ali Shubbar</surname></name></contrib><xref ref-type="aff" rid="aff-a" /></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>Sarah</given-names><surname>Salih Hasan</surname></name></contrib><xref ref-type="aff" rid="aff-a" /></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>Hussein</given-names><surname>Wahhab Rabeea</surname></name></contrib><xref ref-type="aff" rid="aff-a" /></contrib-group><aff-id id="aff-a">Jabir Ibn Hayyan University for Medical and Pharmaceutical Sciences, Faculty of Medicine, Iraq</aff-id><abstract>Ovarian cancer is among the most fatal gynecologic cancers, posing considerable difficulties with early detection, treatment and overall prognosis. This study aims to assess the correlation between the miR-146a rs2910164 polymorphism and the susceptibility to ovarian cancer in an Iraqi population. A total of 130 individuals were enrolled, categorized into two groups: 60 cases and 70 controls. The CC genotype was the most common, observed in 30 cases (38.5%), which was substantially more than the control group, which included 10 controls (14.3%), resulting in an Odds Ratio (OR) of 6.00 (95% CI: 2.56-14.09, p 0.001). The GG genotype exhibited no statistically significant difference between cases (10 cases, 12.8%) and controls (20 controls, 28.6%), indicating a protective effect. The C allele was notably more prevalent in cases (70 alleles, 44.9%) than in controls (40 alleles, 28.6%), with odds ratios of 3.50 (p&amp;lt;0.001) and 0.29 (P=0.001), respectively. This work contributes to the increasing data indicating that this genetic variation may function as a significant diagnostic biomarker and treatment target.</abstract></article-meta></front><body /><back /></article>